HbA1c Analyzers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

HbA1c Analyzers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Leading Market Players Drive Growth Amidst Rising Prevalence of Diabetes and Technological Advancements

The global HbA1c analyzers market is anticipated to witness substantial growth over the forecast period, reaching a valuation of $3 billion by 2031. This surge is primarily attributed to key factors such as the increasing prevalence of diabetes and related disorders, along with the heightened adoption of HbA1c analyzers worldwide.

Rising Prevalence of Diabetes and Diabetes-related Illnesses

As per the International Diabetes Federation, the incidence of diabetes continues to escalate, with approximately 463 million individuals diagnosed in 2019, a figure expected to soar to 700 million by 2045. In this context, the demand for HbA1c analyzers is set to rise significantly, as hemoglobin measurement remains integral in diagnosing and managing diabetes. The market is poised to benefit from the growing necessity for efficient diagnostic tools amidst the surge in diabetes cases globally.

Increased Adoption of HbA1c Analyzers

With an increasing emphasis on regular diabetes monitoring, the adoption of HbA1c analyzers is witnessing a notable upsurge. Diagnostic centers, in particular, are integrating these analyzers into their operations due to their ability to deliver rapid and accurate results, facilitating early intervention and treatment. Moreover, the utilization of HbA1c analyzers for pre-surgery glucose assessments is further fueling market growth, presenting lucrative opportunities for market players.

Technological Advancements

To meet the escalating demand for precise and swift measurements, market leaders are actively engaged in technological advancements and the development of novel testing methodologies and portable devices. These innovations are poised to enhance the efficiency and accuracy of HbA1c testing, thus driving market expansion and bolstering competitive dynamics.

Challenges and Resilience Amidst Covid-19 Pandemic

The COVID-19 pandemic posed significant challenges to the HbA1c analyzers market, with testing volumes and sales experiencing a substantial decline in the initial months of the outbreak. However, the market demonstrated resilience, witnessing a rebound in testing volumes as pandemic-related restrictions eased and vaccination drives proved successful.

Competitive Landscape

The HbA1c analyzers market presents a moderately competitive landscape, characterized by the presence of both domestic and foreign players, with global giants dominating the scene. Emerging market players are actively focused on innovating and introducing new testing methods and devices to expand their market footprint and gain a competitive edge.

Key Companies Driving Market Growth

Leading companies in the HbA1c analyzers market include:
• ApexBio
• EKF Diagnostics
• Bio-Rad Laboratories, Inc.
• Abbott
• F. Hoffmann-La Roche
• ARKRAY, Inc.
• HemoCue
• i-SENS, Inc.
• Meril Life Sciences Pvt. Ltd.
• Trinity Biotech

HbAc Analyzers Market Categorization

HbA1c Analyzers Market by Technology
• High-performance Liquid Chromatography (HPLC)
• Ion Exchange Chromatography
• Boronate Affinity Technology
• Boronate Affinity HPLC

HbA1c Analyzers Market by End-user
• Hospitals
• Specialty Clinics
• Diagnostic Centers
• Others

HbA1c Analyzers Market by Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa (MEA)

Please note: The PDF e-mail from publisher version of this report is for a global site license. Delivery Timelines - 5 working days.